Several workers have suggested the role of genetic factors in the pathogenesis of duodenal ulcer disease. 2 The observations reported increased frequency of the disease in first degree relatives of patients, greater concordance between monozygotic twins than dizygotic twins,3 and the association of ABO blood groups with the disorder.4 5 Reports on the familial aggregation of this disease, however, did not reveal a definite mode of inheritance. This difficulty encountered in elucidating the mode of inheritance of duodenal ulcer is usually attributed to the absence of appropriate genetic markers for the ulcer diathesis. The genetic markers used in the past are ABO blood groups,45 secretor and non-secretor status,5 HLA typing6 and serum pepsinogen-I. 2 Rotter et alt using serum pepsinogen-I concentrations as a subclinical marker found that ulcer patients may be either hyperpepsinogenaemic-I or normopepsinogenaemic-I; the segregation analysis of hyperpepsinogenaemic-I duodenal ulcer in their study agreed with an autosomal dominant mode of inheritance. The frequency of duodenal ulcer in normopepsinogenaemic individuals could not be explained similarly, however, and was attributed to genetic heterogeneity of the disease.
Considering the magnitude of the problem of duodenal ulcer in India we undertook a similar study using total serum pepsinogen concentrations as the marker and have analysed the mode of segregation of serum pepsinogen in families of 100 patients. When the total serum pepsinogen concentration of patients was analysed it was observed that 83% of the patients were hyperpepsinogenaemic while 17% of the patients were normopepsinogenaemic. Among the family members of hyperpepsinogenaemic patients of duodenal ulcer 57.28% were hyperpepsinogenaemic while 42.72% were normopepsinogenaemic. In case of normopepsinogenaemic patients all the family members had normopepsinogenaemia except in one family where the husband of the proposita was hyperpepsinogenaemic as a result of which hyperpepsinogenaemia was recorded in 2/4 of the family members (Table 2) .
Segregation analysis of high total serum pepsinogen concentrations in sibships of hyperpepsinogenaemic patients gave a segregation frequency of 0.56±0*026. On comparison with the predicted ratio of 0.5 for a dominant and 0 25 for a recessive mode of inheritance, we arrive at an autosomal dominant mode of inheritance for hyperpepsinogenaemia. * These values become 100% and zero when it is considered that hyperpepsinogenaemia was introduced into one family by the husband of the proposita.
Discussion
The familial basis of duodenal ulcer and its mode of inheritance have thus far been an enigma, resulting in the emergence of the polygenic hy pothesis9 and the concept of genetic heterogeneity." Rotter et al2
studied the mode of inheritance of hyperpepsinogenaemia-I and concluded that it was an autosomal dominant disorder. Their study, however, was restricted to two large kindreds. In the above mentioned study Rotter et al2 reported that the ulcer patients tended to have either hyperpepsinogenaemia-I or normopepsinogenaemia-I on a familial basis and that hyperpepsinogenaemia-I accounted for 50% of the duodenal ulcers. As the other 50%, a sizable number, could not be accounted for on the basis of hyperpepsinogenaemia-I, they thought that normopepsinogenaemia and ulcer disease had also aggregated on familial basis so that duodenal ulcer with hyperpepsinogenaemia-I and duodenal ulcer with normopepsinogenaemia-I were considered as two definite genetically determined entities. In the present communication we report the results of our study of 100 patients of duodenal ulcer and their family members up to three generations, not confining ourselves to the sibships of the patients. The genetic marker used in our study was total serum pepsinogen. It is interesting to note that genetic studies pertaining to duodenal ulcer disease have not so far been reported using this marker. Rotter and colleagues studied the mode of inheritance of duodenal ulcer using serum PG-I as the marker with the understanding that as PG-I arises from the proximal stomach it might be a better marker of oxyntic mucosal structure and functions than serum PG-II or total pepsinogen levels. Our contention is, though the proximal stomach bears the major part of the chief cell mass the site of ulcer formation is predominantly in the upper part of the duodenum which bears the brunt of the injury and the disintegrating peptic cells of the area may be constantly releasing PG-Il into the serum thereby causing an increase in concentrations of serum PG-II. Hence total serum pepsinogen may be a better serum marker of duodenal ulcer, and in fact Mirksy observed a tendency for higher values of total serum pepsinogen among patients with active lesions.
Plebani et allt recently showed a positive correlation between total serum pepsinogen concentrations and serum pepsinogen-I levels in normal subjects as well as in patients with both gastric and duodenal ulcer, which implies that increase in serum pepsinogen-I is part of an overall increase in total serum pepsinogen levels. The present study revealed that on this basis familial aggregation of hyperpepsinogenaemia and ulcer disease occurred in 83% of the patients. The inheritance of hyperpepsinogenaemia according to our results could be doubtlessly considered to suggest an autosomal dominant mode with complete penetrance. As long as duodenal ulcer was studied using phenotypic characteristic like hyperpepsinogenaemia-I and normopepsinogenaemia-I, there was considerable overlap between the control and patient populations. A comparison of the frequency distribution curve of total serum pepsinogen concentrations in controls and duodenal ulcer patients showed minimum overlapping (Figure) , while serum pepsinogen-I concentrations presented considerable, (50%) overlap between the two populations as in the study of Rotter et al.2 This suggests that duodenal ulcer is primarily associated with high concentrations of total serum pepsinogen because irrespective of its site of origin and immunological characteristics it is the precursor of pepsin. Further the level of serum pepsinogen correlates positively with the level of pepsin in the gastric lumen and may definitely contribute to the pathogenesis of an ulcer while the genetically transmitted high levels of serum pepsinogen may indicate the presence of the ulcer diathesis. We wish to suggest that duodenal ulcer with concomitant hyperpepsinogenaemia be considered as 'primary duodenal ulcer' as the association observed between the two appears to be the rule. It is interesting to note that 54.2% of these patients belonged to blood group 0 another genetic marker of duodenal ulcer.
In a small percentage (17%) of the ulcer patients, hyperpepsinogenaemia was not associated with the disease nor was there association with blood group 0 because only 23.52% of patients belonged to that group, while 54-2% of hyperpepsinogenaemic duodenal ulcer patients did belong to it. Furthermore there was no inheritance of duodenal ulcer seen in the families of these patients with normopepsinogenaemia and duodenal ulcer. Though the numbers are small this may indicate that these ulcers are the result of neuroendocrinological or environmental factors, which are also known to cause ulcer disease. Such a duodenal ulcer may then be considered as 'secondary duodenal ulcer'. In contrast with this 19 patients of duodenal ulcer were encountered among the (309) family members of 83 hyperpepsinogenaemic duodenal ulcer patients and hyperpepsinogenaemia was again associated with their ulcer pointing to its genetic aetiology. Moreover statistically the observed difference (6.15%) between the two samples was 4.9 times its standard error (1.24) hence we conclude that the difference is real.
In the light of this classification duodenal ulcer patients manifesting hyperpepsinogenaemia require further investigation in the family to identify siblings and progeny carrying the trait and thus, at higher risk, so that they could be shielded from aggravating environmental and other factors. On the contrary a duodenal ulcer patient with normopepsinogenaemia may safely be considered to be suffering from non-genetic or 'secondary duodenal ulcer' which does not entail investigating the serum pepsinogen concentration in the family. Being secondary, however, it may enjoin a search for the primary cause and thus aid in exposing an occult disease.
pepsinogen as a genetic marker.
